Immunization of horses with a polyvalent live-attenuated African horse sickness vaccine: Serological response and disease occurrence under field conditions-Reference-Cited by-同舟云学术

Immunization of horses with a polyvalent live-attenuated African horse sickness vaccine: Serological response and disease occurrence under field conditions

Published:2015 Issue: Volume:4 Page:24-28
ISSN:1879-4378
Container-title:Trials in Vaccinology
language:en
Short-container-title:Trials in Vaccinology

Author:

Molini Umberto^ORCID,Marucchella Giuseppe,Maseke Adrianatus,Ronchi Gaetano Federico^ORCID,Di Ventura Mauro,Salini Romolo,Scacchia Massimo,Pini Attilio

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Microbiology

Reference21 articles.

1. African horse sickness;Coetzer,2004

2. African horse sickness;Mellor;Vet. Res.,2004

3. Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness;MacLachlan;Vaccine,2007

4. Evidence for a new field Culicoides vector of African horse sickness in South Africa;Meiswinkel;Prev. Vet. Med.,2003

5. Outbreaks of African horse sickness in Senegal, and methods of control of the 2007 epidemic;Diouf;Vet. Rec.,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling African horse sickness emergence and transmission in the South African control area using a deterministic metapopulation approach;PLOS Computational Biology;2023-09-06

2. African horse sickness vaccination status correlated with disease outcome in South Africa;Journal of the South African Veterinary Association;2023-06

3. Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1;Emerging Infectious Diseases;2022-12

4. Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR-/- mice;Vaccine;2022-08

5. Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance;Vaccines;2022-07-14